Twin reverse arterial perfusion: Timing of intervention

Best Pract Res Clin Obstet Gynaecol. 2022 Nov:84:127-142. doi: 10.1016/j.bpobgyn.2022.03.006. Epub 2022 Mar 29.

Abstract

Twin reverse arterial perfusion (TRAP) sequence is a severe anomaly in monochorionic twins where one twin has profound corporeal underdevelopment and acardia. The normal "pump" co-twin provides blood flow to the acardiac twin through placental anastomoses which may lead to cardiac failure and pump twin demise as well as preterm delivery from severe polyhydramnios. Treatments include radiofrequency ablation, bipolar cord coagulation, and intrafetal laser with each aimed at occluding blood flow to the acardiac twin. However, none of these modalities has proven superior in terms of either pump twin survival or minimization of complications, including preterm premature rupture of membranes, preterm birth, or unexpected co-twin demise. The optimal timing of treatment is also unknown, without clear indications for intervention versus expectant management. Very early treatment of TRAP (i.e., <16 weeks) has been proposed to reduce first-trimester demise; however, this approach remains experimental. Further investigation is required to determine the best treatment and timing of intervention for TRAP.

Keywords: Bipolar cord coagulation; Fetal surgery; Monochorionic twins; Radiofrequency ablation; Selective reduction; Twin reverse arterial perfusion sequence.

Publication types

  • Review

MeSH terms

  • Female
  • Fetofetal Transfusion* / surgery
  • Heart Defects, Congenital*
  • Humans
  • Infant, Newborn
  • Perfusion
  • Placenta
  • Pregnancy
  • Pregnancy Reduction, Multifetal
  • Premature Birth*